Jump to content


Biomarker for Diffuse Scleroderma skin has been discovered!


Photo

Low-dose UVA1 phototherapy for scleroderma: what benefit can we expect?


  • Please log in to reply
No replies to this topic

#1 Joelf

Joelf

    Star Ruby Member

  • ISN Root Admin
  • PipPipPipPipPipPipPipPipPipPipPipPipPip
  • 4,610 posts
  • Location:West Sussex

Posted 10 January 2013 - 12:55 PM

Low-dose UVA1 phototherapy for scleroderma: what benefit can we expect?

In patients with morphea, a marked improvement was found in 77.8% patients and a moderate improvement was found in 11.1% patients. In the systemic scleroderma group, a patient with complete remission of the skin sclerosis is emphasized. PubMed. J Eur Acad Dermatol Venereol. 2012 May;26(5):619-26. (Also see: Morphea Treatments and Skin Fibrosis Treatments)

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.

Jo Frowde
ISN Assistant Webmaster

SD World Webmaster
ISN Sclero Forums Manager
ISN News Manager

ISN Hotline Support Specialist
ISN Chat Host
International Scleroderma Network (ISN)